Small Molecule | Gefitinib | PubChem CID 1236313D Model
Small Molecule | Gefitinib | PubChem CID 123631
127
127 Downloads
505
505 Views
4Like
Triangles: 25.4k
Vertices: 15.5k
More model informationGefitinib is an anilinoquinazoline with antineoplastic activity. Gefitinib inhibits the catalytic activity of numerous tyrosine kinases including the epidermal growth factor receptor (EGFR), which may result in inhibition of tyrosine kinase-dependent tumor growth. Specifically, this agent competes with the binding of ATP to the tyrosine kinase domain of EGFR, thereby inhibiting receptor autophosphorylation and resulting in inhibition of signal transduction. Gefitinib may also induce cell cycle arrest and inhibit angiogenesis. (NCI04)
Download from NIH 3D Print Exchange: http://3dprint.nih.gov/discover/3dpx-003112
CC AttributionCreative Commons Attribution
Sep 9th 2016
Comments